HHS ham­mers in­dus­try's at­tempt to de­lay new drug price ne­go­ti­a­tions

Lawyers for HHS on Fri­day sharply crit­i­cized the US Cham­ber of Com­merce’s at­tempt to stall the im­ple­men­ta­tion of new drug pric­ing ne­go­ti­a­tions, set to be­gin on Sept. 1.

While call­ing the busi­ness lob­by­ing group’s claims “hy­per­bol­ic,” the US gov­ern­ment lawyers said the cham­ber is es­sen­tial­ly try­ing to do in court what it failed to do while lob­by­ing Con­gress over the In­fla­tion Re­duc­tion Act that set up these ne­go­ti­a­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER